Whitehead Institute for Biomedical Research

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9476
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 6065
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 53202
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 4059
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 39167
 
  
 
C07K PEPTIDES 31105
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1683
 
  
 
A01K ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS1335
 
  
 
C07D HETEROCYCLIC COMPOUNDS 11151
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1085

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0369,937 HiC: Method of Identifying Interactions Between Genomic LociJun 15, 17Dec 28, 17[C12Q]
2017/0267,970 Three-Dimensional Hydrogels that Support Growth of Physiologically Relevant Tissue and Methods of Use ThereofFeb 28, 17Sep 21, 17[C12N, A01K, G01N, A61L]
2017/0258,772 COMPOSITIONS AND METHODS FOR PROMOTING INTESTINAL STEM CELL AND/OR NON-STEM PROGENITOR CELL FUNCTIONMay 29, 15Sep 14, 17[A61K]
2017/0166,928 Compositions And Methods For Genetically Modifying YeastApr 02, 16Jun 15, 17[C12N]
2017/0114,323 USES OF KINASE INHIBITORS FOR INDUCING AND MAINTAINING PLURIPOTENCYJun 19, 15Apr 27, 17[C12N]
2017/0066,797 WITHAFERIN A ANALOGS AND USES THEREOFJun 07, 16Mar 09, 17[C07J]
2017/0067,081 NUCLEIC ACID CONSTRUCTS ENCODING REPROGRAMMING FACTORS LINKED BY SELF-CLEAVING PEPTIDESNov 17, 16Mar 09, 17[C12N, C07K]
2017/0009,242 CRISPR-Mediated Genome Engineering for Protein DepletionJul 06, 16Jan 12, 17[C12N, C07K]
2016/0340,749 REPORTER OF GENOMIC METHYLATION AND USES THEREOFMar 23, 16Nov 24, 16[C12Q, G01N]
2016/0319,239 COMPOSITIONS AND METHODS FOR CULTURING CELLS FROM NORMAL HUMAN TUBO-OVARIAN EPITHELIUM AND HUMAN TUBO-OVARIAN TUMORSMay 05, 16Nov 03, 16[C12N, G01N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9909160 Modulators of alpha-synuclein toxicityDec 21, 15Mar 06, 18[C07H, C12Q, G01N]
9879257 Modulators of alpha-synuclein toxicityMar 24, 15Jan 30, 18[A61K, C12N, G01N]
9834787 Targeted integration into stem cellsApr 08, 10Dec 05, 17[A61K, C12Q, C12P, C12N]
9822156 Amyloid beta expression constructs and uses thereforJun 12, 15Nov 21, 17[C12N, G01N, C07K]
9790188 Benzimidazole derivatives and uses thereofMar 17, 14Oct 17, 17[A61K, C07D]
9751945 Sortase-modified VHH domains and uses thereofApr 15, 13Sep 05, 17[A61K, C12N, G01N, C07K]
9746470 Chaperone interaction assays and uses thereofMay 09, 12Aug 29, 17[C12Q, G01N]
9738610 Indazole derivatives and uses thereofSep 24, 13Aug 22, 17[A61K, C07D, A61P]
9738898 Yeast cells expressing TAR DNA-binding protein 43 and uses thereforFeb 13, 09Aug 22, 17[C12N, G01N]
9714414 Reprogramming of somatic cellsAug 29, 14Jul 25, 17[C12N, A01K, G01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0053,272 Methods Of Modifying A Sequence Using CRISPRAbandonedJul 16, 15Feb 25, 16[C12N]
2016/0053,304 Methods Of Depleting Target Sequences Using CRISPRAbandonedJul 17, 15Feb 25, 16[C12Q]
2015/0337,376 Core Transcriptional Circuitry in Human Cells and Methods of Use ThereofAbandonedMar 19, 15Nov 26, 15[C12Q]
2015/0259,644 HORMONE RESPONSIVE TISSUE CULTURE SYSTEM AND USES THEREOFAbandonedDec 15, 14Sep 17, 15[C12N]
2015/0241,436 HSF1 AND HSF1 CANCER SIGNATURE SET GENES AND USES RELATING THERETOAbandonedMay 03, 13Aug 27, 15[G01N]
2015/0126,377 SELECTION OF NUCLEIC ACIDS BY SOLUTION HYBRIDIZATION TO OLIGONUCLEOTIDE BAITSAbandonedOct 08, 14May 07, 15[C12Q]
2015/0072,391 ETHANOL PRODUCTION IN ENGINEERED YEASTAbandonedSep 05, 14Mar 12, 15[C12P, C12N]
2015/0065,556 THERAPEUTIC TARGETS FOR MITOCHONDRIAL DISORDERSAbandonedAug 05, 14Mar 05, 15[C12Q, C12N, G01N]
8957197 RNA sequence-specific mediators of RNA interferenceWithdrawnJan 18, 11Feb 17, 15[C07H]
2014/0348,749 IDENTIFICATION AND TREATMENT OF TUMORS SENSITIVE TO GLUCOSE LIMITATIONAbandonedFeb 25, 14Nov 27, 14[G01N]
2014/0308,747 Ex Vivo Expansion of Human Hematopoietic Stem CellsAbandonedNov 12, 13Oct 16, 14[C12N]
2014/0296,218 SUPER-ENHANCERS AND METHODS OF USE THEREOFAbandonedOct 25, 13Oct 02, 14[C12Q, C12N]
2014/0287,932 SUPER-ENHANCERS AND METHODS OF USE THEREOFAbandonedOct 25, 13Sep 25, 14[C12N]
2014/0234,266 Cultured Hematopoietic Stem Cells and Method for Expansion and Analysis ThereofAbandonedNov 26, 13Aug 21, 14[C12N]
2014/0187,613 METHODS AND PRODUCTS FOR EXPRESSION OF MICRO RNAsAbandonedNov 18, 13Jul 03, 14[C12N]
2014/0170,693 COMPOSITIONS AND METHODS FOR CULTURING CELLS FROM NORMAL HUMAN TUBO-OVARIAN EPITHELIUM AND HUMAN TUBO-OVARIAN TUMORSAbandonedMar 23, 12Jun 19, 14[G01N]
2014/0142,180 METHODS OF TREATING TUMORS HAVING ELEVATED MCT1 EXPRESSIONAbandonedOct 04, 13May 22, 14[A61K, G01N]
2014/0087,970 SERINE BIOSYNTHESIS PATHWAY INHIBITION FOR TREATMENT OF CANCERAbandonedMar 30, 12Mar 27, 14[C12Q, C12N, G01N]
2014/0030,697 SORTASE-MEDIATED MODIFICATION OF VIRAL SURFACE PROTEINSAbandonedJun 14, 13Jan 30, 14[C12N]
8617885 Cultured hematopoietic stem cells and method for expansion and analysis thereofExpiredJul 06, 10Dec 31, 13[C12N]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.